(ORCL) Oracle - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 679.725m USD | Total Return: 20.8% in 12m
Avg Turnover: 3.60B
EPS Trend: 94.7%
Qual. Beats: 0
Rev. Trend: 97.7%
Qual. Beats: 1
Warnings
High Debt while negative Cash Flow
Tailwinds
Supp Ema20
Oracle Corporation (NYSE: ORCL) is a global provider of enterprise information technology solutions, specializing in cloud-based software as a service (SaaS) and infrastructure technologies. Its product suite includes enterprise resource planning (ERP), supply chain management (SCM), and human capital management (HCM) through platforms like Oracle Fusion and NetSuite. The company also maintains a significant presence in database management with Oracle Database and MySQL, alongside infrastructure services such as cloud compute, storage, and networking.
Operating within the systems software sub-industry, Oracle utilizes a high-margin recurring revenue model driven by cloud license support and software subscriptions. The enterprise software sector is characterized by high switching costs, as integrated ERP and database systems often become deeply embedded in a clients core operational workflow. Beyond software, Oracle provides engineered hardware systems and consulting services to government agencies, educational institutions, and private enterprises.
For a more detailed analysis of these fundamentals, consider exploring the data available on ValueRay.
- Cloud infrastructure revenue growth accelerates through AI training and inference demand
- Oracle Fusion and NetSuite ERP expansion drives high-margin recurring subscription revenue
- Strategic cloud partnerships with Azure and Google expand database market reach
- High capital expenditure requirements for data center expansion pressure short-term free cash flow
- Integration of Oracle Health and Cerner optimizes vertical software revenue streams
| Net Income: 16.2b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA -13.69 > 1.0 |
| NWC/Revenue: 22.06% < 20% (prev 0.88%; Δ 21.18% < -1%) |
| CFO/TA 0.10 > 3% & CFO 23.5b > Net Income 16.2b |
| Net Debt (142b) to EBITDA (29.3b): 4.83 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.91b) vs 12m ago 1.39% < -2% |
| Gross Margin: 66.44% > 18% (prev 71.12%; Δ -4.68% > 0.5%) |
| Asset Turnover: 31.52% > 50% (prev 34.57%; Δ -3.05% > 0%) |
| Interest Coverage Ratio: 5.44 > 6 (EBIT TTM 22.5b / Interest Expense TTM 4.14b) |
| A: 0.06 (Total Current Assets 54.9b - Total Current Liabilities 40.7b) / Total Assets 245b |
| B: -0.03 (Retained Earnings -7.09b / Total Assets 245b) |
| C: 0.11 (EBIT TTM 22.5b / Avg Total Assets 203b) |
| D: 0.19 (Book Value of Equity 38.5b / Total Liabilities 206b) |
| Altman-Z'' = 1.22 = BB |
| DSRI: 1.16 (Receivables 10.7b/8.05b, Revenue 64.1b/55.8b) |
| GMI: 1.07 (GM 71.12% / 66.44%) |
| AQI: 0.71 (AQ_t 0.44 / AQ_t-1 0.62) |
| SGI: 1.15 (Revenue 64.1b / 55.8b) |
| TATA: -0.03 (NI 16.2b - CFO 23.5b) / TA 245b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of June 09, 2026, the stock is trading at USD 211.82 with a total of 17,168,960 shares traded.
Over the past week, the price has changed by -14.64%,
over one month by +8.10%,
over three months by +40.25% and
over the past year by +20.77%.
Oracle has received a consensus analysts rating of 4.13. Therefore, it is recommended to buy ORCL.
- StrongBuy: 20
- Buy: 4
- Hold: 15
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 248.8 | 17.4% |
P/E Trailing = 42.3548
P/E Forward = 30.4878
P/S = 10.3383
P/B = 20.972
P/EG = 1.5471
Revenue TTM = 64.1b USD
EBIT TTM = 22.5b USD
EBITDA TTM = 29.3b USD
Long Term Debt = 125b USD (from longTermDebt, last quarter)
Short Term Debt = 13.2b USD (from shortTermDebt, last quarter)
Debt = 181b USD (from shortLongTermDebtTotal, last quarter) + Leases 18.5b
Net Debt = 142b USD (calculated: Debt 181b - CCE 39.1b)
Enterprise Value = 821b USD (680b + Debt 181b - CCE 39.1b)
Interest Coverage Ratio = 5.44 (Ebit TTM 22.5b / Interest Expense TTM 4.14b)
EV/FCF = -33.20x (Enterprise Value 821b / FCF TTM -24.7b)
FCF Yield = -3.01% (FCF TTM -24.7b / Enterprise Value 821b)
FCF Margin = -38.60% (FCF TTM -24.7b / Revenue TTM 64.1b)
Net Margin = 25.30% (Net Income TTM 16.2b / Revenue TTM 64.1b)
Gross Margin = 66.44% ((Revenue TTM 64.1b - Cost of Revenue TTM 21.5b) / Revenue TTM)
Gross Margin QoQ = 62.16% (prev 66.53%)
Tobins Q-Ratio = 3.35 (Enterprise Value 821b / Total Assets 245b)
Interest Expense / Debt = 2.29% (Interest Expense 4.14b / Debt 181b)
Taxrate = 11.56% (2.13b / 18.4b)
NOPAT = 19.9b (EBIT 22.5b * (1 - 11.56%))
Current Ratio = 1.35 (Total Current Assets 54.9b / Total Current Liabilities 40.7b)
Debt / Equity = 4.69 (Debt 181b / totalStockholderEquity, last quarter 38.5b)
Debt / EBITDA = 4.83 (Net Debt 142b / EBITDA 29.3b)
Debt / FCF = -5.72 (negative FCF - burning cash) (Net Debt 142b / FCF TTM -24.7b)
Total Stockholder Equity = 28.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.97% (Net Income 16.2b / Total Assets 245b)
RoE = 57.35% (Net Income TTM 16.2b / Total Stockholder Equity 28.3b)
RoCE = 14.72% (EBIT 22.5b / Capital Employed (Equity 28.3b + L.T.Debt 125b))
RoIC = 9.28% (NOPAT 19.9b / Invested Capital 215b)
WACC = 10.66% (E(680b)/V(860b) * Re(12.95%) + D(181b)/V(860b) * Rd(2.29%) * (1-Tc(0.12)))
Discount Rate = 12.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 1.52%
[DCF] Fair Price = unknown (Cash Flow -24.7b)
EPS Correlation: 94.66 | EPS CAGR: 11.18% | SUE: 0.32 | # QB: 0
Revenue Correlation: 97.73 | Revenue CAGR: 8.63% | SUE: 1.75 | # QB: 1
EPS current Quarter (2026-08-31): EPS=1.68 | Chg30d=+0.18% | Revisions=+0% | Analysts=27
[Analyst] Revisions Ratio: +0%